Risk of Clinically Significant Graft-Versus-Host Disease (CSGVHD) in Children Receiving Allogeneic Hematopoietic Cell Transplant (HCT) for Non-Malignant Disorders in Florida (2010-2019)

Authors :: Biljana Horn
Mustafa Hanif
Deepak Chellapandian
Warren Alperstein
Mansi Dalal
Paul Castillo
Fan Yang
Edward Ziga
Jessica Cline
Howard M. Katzenstein
John Fort
Jing Zhao
Benjamin Oshrine
Gauri Sunkersett
Michael Joyce
Jorge Galvez-Silva
Source :: Transplantation and Cellular Therapy. 27:S289
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
Transplantation
medicine.medical_specialty
Hematopoietic cell
business.industry
Non malignant
Cell Biology
Hematology
medicine.disease
Graft-versus-host disease
Internal medicine
Molecular Medicine
Immunology and Allergy
Medicine
business

Tools